Form 13-F position report

SAREPTA THERAPEUTICS INC

Reported by CHOREO LLC

SRPT 1.25 09/15/27 CUSIP 803607AD2 Manager CIK 0001679031

Reported 25,000 shares, down 9,000 (26.5%) from the prior quarter.

Reported value -37.9%; share count -26.5% vs. the prior quarter.

Reduced
% of reported 13F value < 0.01% This manager · Q1 2025
Shares 25,000 Quarter-end amount reported
Reported value $23,227 Fair value at quarter end
Consecutive quarters held 4 Through Q1 2025

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2024-06-30 19248
2024-09-30 19067
2024-12-31 37426
2025-03-31 23227
2025-06-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

5 quarters
Quarterly reported position history for SAREPTA THERAPEUTICS INC held by CHOREO LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2025 Reduced 0 -25,000 (-100.0%) 0 $0 2025-08-13
Q1 2025 Reduced 25,000 -9,000 (-26.5%) < 0.01% $23,227 2025-05-06
Q4 2024 Added 34,000 +17,000 (100.0%) < 0.01% $37,426 2025-01-27
Q3 2024 Added 17,000 +2,000 (13.3%) < 0.01% $19,067 2024-11-07
Q2 2024 New 15,000 +15,000 (0.0%) < 0.01% $19,248 2024-08-07

Who else reported the position

92 managers reported SAREPTA THERAPEUTICS INC for Q1 2025.

Managers reporting SAREPTA THERAPEUTICS INC in Q1 2025.
Manager Activity Shares Change % of reported 13F Reported value Tenure
Linden Advisors LP Added 153,106,000 +62,500,000 0.97% $142,494,637 7 qtrs
TENOR CAPITAL MANAGEMENT Co L P Added 81,500,000 +26,500,000 1.09% $76,205,406 7 qtrs
Calamos Advisors LLC Added 59,159 +6 0.24% $55,146,245 7 qtrs
BANK OF MONTREAL Unchanged 53,000,000 0 0.02% $49,380,100 7 qtrs
Davidson Kempner Capital Management LP Unchanged 0 0 0.64% $48,746,250 7 qtrs
Voya Investment Management LLC Reduced 48,775,000 -51,420,000 0.05% $45,409,525 7 qtrs
ADVENT CAPITAL MANAGEMENT DE Reduced 47,667,000 -13,658,000 0.97% $44,377,977 7 qtrs
Opti Capital Management LP New 45,877,000 +45,877,000 2.63% $42,952,341 1 qtr
WOLVERINE ASSET MANAGEMENT LLC Unchanged 0 0 0.45% $37,701,414 1 qtr
LAZARD ASSET MANAGEMENT LLC Reduced 39,219,000 -829,000 0.06% $36,512,000 7 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
March 31, 2025
Filed
May 06, 2025
Filing type
13F-HR
Position type
NOTE 1.250% 9/1

Voting authority reported

Sole
0
Shared
0
None
25,000

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.